. Author manuscript; available in PMC: 2019 Mar 2.

Published in final edited form as: J Mol Biol. 2018 Jan 10;430(5):695–709. doi: 10.1016/j.jmb.2018.01.002

Table 1.

¹³C, ¹⁵N-labeled (red underlined) and fluorinated (blue bolded) residues in the PIV5F TMD (485–510) peptides used in this study

	Samples	Labeled residues	POPC/ Chol	POPE
1	IAGLSV: I488, A490, G497, L498, S505, V506		x	x
2	1:1 mixed GV and IS G494, V506 and I501, S505		x	x
3	ILSILV: I491, L493, S495, I499, L500, V508		x	x
4	AGILV (L493F): A492, 4- ¹⁹F-L493F, G494, I502, L503, V507		x	x
5	1:1 mixed ILSILV and AGILV (L493F)		-	x
6	Diluted ILSILV	ILSILV : Unlabeled peptide = 1: 2	x	-
7	L504F		x	-
8	L500F		x	-

Sample 1 (IAGLSV) was used in a previously reported study [32], while samples 2–8 are produced specifically for this study.